ArticleFrontiers in oncology2026
Integrating contrast-enhanced ultrasound to optimize margin delineation in Mohs micrographic surgery for primary dermatofibrosarcoma protuberans: a retrospective cohort study.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Dermatofibrosarcoma protuberans (DFSP) is characterized by infiltrative "tentacle-like" extensions, making accurate preoperative margin delineation challenging. While high-frequency ultrasound (HFUS) visualizes subclinical spread, its ability to fully capture tumor extent remains limited. Contrast-enhanced ultrasound (CEUS), by depicting microvascular perfusion, may improve delineation, but its clinical impact on Mohs micrographic surgery (MMS) remains unclear. Methods: This retrospective cohort study included 220 primary DFSP patients treated with MMS. Preoperative margin delineation utilized HFUS-only or HFUS+CEUS. The primary outcome was extra peripheral Mohs stages. Secondary outcomes included extra deep and total stages, margin positivity, and other surgical characteristics. Multivariable Poisson regression with LASSO-based variable selection was used, alongside cohort-restriction, covariate-specification, and propensity score-matched (PSM) analyses. Risk-stratified and subgroup analyses explored effect heterogeneity. Results: HFUS+CEUS was associated with fewer extra peripheral Mohs stages than HFUS-only (adjusted incidence rate ratio [aIRR], 0.310; P = 0.049). Peripheral margin positivity was reduced from 17.4% to 5.1% (P = 0.020). These findings were consistent across sensitivity analyses and in the PSM cohort (aIRR, 0.309; P = 0.033). The relative effect was most pronounced in the high-risk stratum (IRR, 0.124; P = 0.041), although interaction testing was not statistically significant (P = 0.077). No significant differences were observed in deep or total stages, likely due to ultrasound depth limitations. Conclusions: Integrating CEUS with HFUS enhances the precision of preoperative margin delineation for DFSP, reducing extra peripheral Mohs stages. This multimodal imaging strategy represents a valuable, tissue-sparing refinement to the preoperative workflow of MMS, particularly for patients with higher baseline risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.